Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
- PMID: 1279432
- DOI: 10.1038/359845a0
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
Abstract
Clinical and experimental studies suggest that angiogenesis is a prerequisite for solid tumour growth. Several growth factors with mitogenic or chemotactic activity for endothelial cells in vitro have been described, but it is not known whether these mediate tumour vascularization in vivo. Glioblastoma, the most common and most malignant brain tumour in humans, is distinguished from astrocytoma by the presence of necroses and vascular proliferations. Here we show that expression of an endothelial cell-specific mitogen, vascular endothelial growth factor (VEGF), is induced in astrocytoma cells but is dramatically upregulated in two apparently different subsets of glioblastoma cells. The high-affinity tyrosine kinase receptor for VEGF, flt, although not expressed in normal brain endothelium, is upregulated in tumour endothelial cells in vivo. These observations strongly support the concept that tumour angiogenesis is regulated by paracrine mechanisms and identify VEGF as a potential tumour angiogenesis factor in vivo.
Similar articles
-
Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.Cancer Res. 1999 Nov 1;59(21):5608-14. Cancer Res. 1999. PMID: 10554042
-
Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.Cancer Res. 2001 Dec 1;61(23):8569-77. Cancer Res. 2001. PMID: 11731444
-
Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.Cancer Res. 1996 Jan 15;56(2):393-401. Cancer Res. 1996. PMID: 8542597
-
Angiogenesis in malignant gliomas.Glia. 1995 Nov;15(3):339-47. doi: 10.1002/glia.440150313. Glia. 1995. PMID: 8586468 Review.
-
Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review.
Cited by
-
Investigating Glioblastoma Response to Hypoxia.Biomedicines. 2020 Aug 27;8(9):310. doi: 10.3390/biomedicines8090310. Biomedicines. 2020. PMID: 32867190 Free PMC article.
-
Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes.J Immunol. 2010 Sep 1;185(5):3028-34. doi: 10.4049/jimmunol.1001298. Epub 2010 Jul 28. J Immunol. 2010. PMID: 20668222 Free PMC article.
-
Vascular endothelial growth factors and vascular permeability.Cardiovasc Res. 2010 Jul 15;87(2):262-71. doi: 10.1093/cvr/cvq105. Epub 2010 Apr 16. Cardiovasc Res. 2010. PMID: 20400620 Free PMC article. Review.
-
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.Neuro Oncol. 2010 Aug;12(8):822-33. doi: 10.1093/neuonc/noq017. Epub 2010 Feb 23. Neuro Oncol. 2010. PMID: 20179017 Free PMC article.
-
Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.J Neurooncol. 2010 Oct;100(1):17-29. doi: 10.1007/s11060-010-0139-3. Epub 2010 Feb 24. J Neurooncol. 2010. PMID: 20179990 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical